Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Cytek Biosciences, Inc.

Get SEC filing alerts via email and in your feed for Cytek Biosciences, Inc.

CTKB

Cytek Biosciences, Inc.

About Cytek Biosciences, Inc.

Cytek Biosciences specializes in innovative cell analysis solutions, leveraging full spectrum fluorescence profiling for high-resolution, multiplexed flow cytometry and cell sorting. Its products serve biomedical research, clinical diagnostics, and drug development markets worldwide, enabling detailed single-cell analysis. The company offers advanced instruments, reagents, and software that improve sensitivity, flexibility, and efficiency, supporting scientific discovery and personalized medicine through comprehensive, integrated workflows.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Cytek Biosciences, Inc.

1
1
Cytek Biosciences, Inc. Cytek Biosciences Reports $44.1 Million Revenue with 6% Growth and $18.9 Million Net Loss

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Cytek Biosciences, Inc. Cytek Biosciences Reports $201.5 Million Revenue and $66.5 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Cytek Biosciences, Inc. Cytek Biosciences Reports Q3 Revenue Growth of 2% to $52.3M, Net Loss of $5.5M

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Cytek Biosciences, Inc. Cytek Biosciences Reports Q2 2025 Revenue Decline to $45.6 Million

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Cytek Biosciences, Inc. Cytek Biosciences Reports $41.5 Million Revenue with Increased Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Cytek Biosciences, Inc. Cytek Biosciences Reports $200.5M Revenue and $6M Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Cytek Biosciences, Inc. Cytek Biosciences Reports 7% Revenue Growth in Q3 2024, Narrowed Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments